Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement

BACKGROUND: In most jurisdictions, policies have been adopted to encourage the development of treatments for rare or orphan diseases. While successful as assessed against their primary objective, these policies have prompted concerns among payers about the economic burden that might be caused by an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlander, Michael, Garattini, Silvio, Kolominsky-Rabas, Peter, Nord, Erik, Persson, Ulf, Postma, Maarten, Richardson, Jeff, Simoens, Steven, de Solà-Morales, Oriol, Tolley, Keith, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087264/
https://www.ncbi.nlm.nih.gov/pubmed/27857828
http://dx.doi.org/10.3402/jmahp.v4.33039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087264/
https://www.ncbi.nlm.nih.gov/pubmed/27857828
http://dx.doi.org/10.3402/jmahp.v4.33039

Ejemplares similares